KS

Kuttapalayam Songappan Ramalingam

Active Director Director DIN 01016571
DIN 01016571 First appointment Jun 1990 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since Jun 1990
Shareholding value •••• Premium profile

About Kuttapalayam Songappan Ramalingam

Data last updated:

Kuttapalayam Songappan Ramalingam is a Director at Lotus Eye Hospital And Institute Limited (since 2021), Director at Coimbatore Kidney Care And Research Limited (since 1990) and Managing Director at Coimbatore Healthcare Investors Private Limited (since 2022), and holds 1 more current directorship. The companies operate in Healthcare and Financial Services. The 2 current companies with reported revenue have a combined latest revenue of ₹83.04 Cr; the largest is Lotus Eye Hospital And Institute Limited at ₹50.86 Cr (FY 2025). Earlier, Kuttapalayam Songappan Ramalingam was a Director at Respire Medicals Private Limited (1994–2018).

DIN 01016571
Primary Designation Director
Industry Healthcare
First Appointment 19 Jun 1990
Oldest Company Age 36 yrs
Largest company Lotus Eye Hospital And Institute Limited · ₹50.86 Cr (FY 2025)
Combined revenue ₹83.04 Cr across 2 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Feb 20211997₹50.86 Cr (FY 2025)Active
Director19 Jun 19901990₹32.18 Cr (FY 2024)Active
Managing Director31 Jan 20222022Active
Director13 Jun 19951995Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Respire Medicals Private Limited U33112TZ1994PTC005078
Director23 May 19941994Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Coimbatore Healthcare Investors Private Limited
Coimbatore Kidney Care And Research Limited
Medserve Diagnostic Services Private Limited
Lotus Eye Hospital And Institute Limited
Premium access

Shareholding and investment profile for Kuttapalayam Songappan Ramalingam

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kuttapalayam Songappan Ramalingam

Kuttapalayam Songappan Ramalingam currently holds 4 directorships: Lotus Eye Hospital And Institute Limited (Director, since 10 Feb 2021, revenue ₹50.86 Cr (FY 2025)); Coimbatore Kidney Care And Research Limited (Director, since 19 Jun 1990, revenue ₹32.18 Cr (FY 2024)); Coimbatore Healthcare Investors Private Limited (Managing Director, since 31 Jan 2022); Medserve Diagnostic Services Private Limited (Director, since 13 Jun 1995).

Kuttapalayam Songappan Ramalingam was first appointed on 19 Jun 1990 as Director at Coimbatore Kidney Care And Research Limited. The most recent appointment on record is 31 Jan 2022 at Coimbatore Healthcare Investors Private Limited.

The 2 current companies of Kuttapalayam Songappan Ramalingam that report revenue have a combined latest revenue of ₹83.04 Cr: Lotus Eye Hospital And Institute Limited ₹50.86 Cr (FY 2025); Coimbatore Kidney Care And Research Limited ₹32.18 Cr (FY 2024).

Kuttapalayam Songappan Ramalingam held 1 earlier board appointment: Respire Medicals Private Limited (Director, 23 May 1994 to 17 Mar 2018).

The current boards of Kuttapalayam Songappan Ramalingam's companies include Gopalakrishnan Karthik Veeramani (Lotus Eye Hospital And Institute Limited), Perumalswamy Mahendran (Lotus Eye Hospital And Institute Limited), Ramanujam Reghunathan (Lotus Eye Hospital And Institute Limited), Sengodagounder Natesan (Lotus Eye Hospital And Institute Limited), Senthilkumar Prathish (Lotus Eye Hospital And Institute Limited), Sundaramoorthy Kavetha (Lotus Eye Hospital And Institute Limited), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available